For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

23 January 2007
The 9th NPS Evaluation Report, Progress, Achievements and Future Directions, indicates an improvement in consumer behaviour around Quality Use of Medicines.Consumers are becoming more active in the management of their health with an increase in the number of people who reported asking questions of their doctor and pharmacist when being prescribed a new medicine.
Awareness of Consumer Medicine Information (CMI) leaflets has also increased from 24% in 2003 to 37% in 2006, and requests for CMI leaflets have increased from 13% in 2003 to 32% in 2006.
“Provision of independent medicines information for consumers continues to be a priority for NPS. We provide information and services nationally to population based groups including older people, people with chronic conditions, multicultural communities, and Aboriginal and Torres Strait Islander communities” said Dr Lynn Weekes, CEO.
“Other highlights from the report include a positive change in GP prescribing of asthma medications and proton pump inhibitors following NPS’s GP education programs which are delivered locally through divisions of general practice.
“At 30 June 2006 NPS had contracts with 115 divisions which is an increase from 43 in 1999 and now covers 97% of divisions. There have been 47 000 educational visits since 1998, providing one-to-one contacts for 14 000 individual GPs.
“Currently about 50% of GPs are actively participating each year in NPS activities in addition to receiving NPS print publications.
“NPS RADAR, a publication that provides information on new drugs and PBS listings for health professionals appears to have had an impact on attitudes and prescribing.
“Attitude change was most often reported by pharmacists (90%), followed by GPs (88%). Almost 89% of GPs and 75% of other medical specialists indicated that their prescribing had also been influenced by NPS RADAR,” said Dr Weekes.
NPS has further improved economic outcomes by providing over $304.4 million in savings to the Pharmaceutical Benefits Scheme since 1998.
The full report is available on the NPS website: www.nps.org.au
ENDS
NPS is an independent, non-profit organisation for Quality Use of Medicines funded by the Australian Government Department of Health and Ageing.
Media enquiries
Contact us
Date published: 2007-01-23 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.